OVIT (OncoVista Innovative Therapies) Ending Cash Position: $0.06 Mil (As of Sep. 2015)


What is OncoVista Innovative Therapies Ending Cash Position?

OncoVista Innovative Therapies OVIT Ending Cash Position is $0.06 Mil as of Sep. 2015.

OncoVista Innovative Therapies's Ending Cash Position for the quarter that ended in Sep. 2015 was $0.06 Mil.

OncoVista Innovative Therapies's quarterly Ending Cash Position declined from Mar. 2015 ($0.06 Mil) to Jun. 2015 ($0.03 Mil) but then increased from Jun. 2015 ($0.03 Mil) to Sep. 2015 ($0.06 Mil).

OncoVista Innovative Therapies's annual Ending Cash Position declined from Dec. 2012 ($0.51 Mil) to Dec. 2013 ($0.05 Mil) and declined from Dec. 2013 ($0.05 Mil) to Dec. 2014 ($0.01 Mil).

OncoVista Innovative Therapies Ending Cash Position Related Terms

OncoVista Innovative Therapies Ending Cash Position Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies Ending Cash Position Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.52 2.13 0.51 0.05 0.01

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.01 0.06 0.03 0.06

OncoVista Innovative Therapies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

OncoVista Innovative Therapies's Ending Cash Position for the fiscal year that ended in Dec. 2014 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.045+-0.032
=0.01

OncoVista Innovative Therapies's Ending Cash Position for the quarter that ended in Sep. 2015 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.028+0.033
=0.06

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.06 Mil mean?
OncoVista Innovative Therapies (OVIT) has a Ending Cash Position of $0.06 Mil as of Sep. 2015. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' Ending Cash Position too high?
OncoVista Innovative Therapies' current Ending Cash Position is $0.06 Mil.
How does OncoVista Innovative Therapies' Ending Cash Position compare to RSPI and HSTC?
OncoVista Innovative Therapies' Ending Cash Position of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current Ending Cash Position is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current Ending Cash Position of $0.06 Mil. The current Ending Cash Position is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current Ending Cash Position is $0.06 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.